ACC plays a critical role in maintaining cell survival in low glucose conditions.
A post-cetuximab increase in total ACC contributes to cetuximab resistance.
ACC rewires cancer metabolism from glycolysis-dependent to lipogenesis-dependent.
Cetuximab plus ACC inhibitor enhances response of cetuximab-resistant HNSCC cells.